Phoreus Blog: All Posts - Phoreus Biotech

February 2024

How Biopesticides Are Harnessing the Power of Nature

Harsh and toxic chemicals have become many agricultural industries’ default pest control strategy. They’re cheap and convenient, but they wreak havoc on the environment and often stunt the growth of beneficial soil organisms. However, with…

Read Article

February 2024

Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers

OLATHE, Kan., February 7, 2024 – Phoreus Biotech, an innovator in peptide nanocarriers for drug and vaccine delivery, is proud to announce the appointment of David Schaefer as its new Chief Executive Officer. With more…

Read Article

Nanoparticles Floating With a Colorful Background

February 2024

The Importance of Low-Toxicity Nanoparticles

Nanoparticles have revolutionized medical drug delivery, offering unparalleled precision and efficiency in treating various health conditions. However, inflammation and other toxicological effects remain a primary concern for human health applications. At Phoreus Biotech, we strive…

Read Article

December 2023

Phoreus Biotech Releases New Data to Support Elimination of Cold-Chain Storage Requirements for mRNA Vaccines and Therapeutics

OLATHE, KS, Dec. 22, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, has announced today the results of two recent studies that demonstrate advancements in shelf-stability for mRNA vaccines and therapeutics. The…

Read Article

April 2023

New Nanocarrier Technology Promises Breakthrough in Delivery of Therapeutic Drugs Through Mucosal Membranes

OLATHE, KS, Apr. 13, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, has announced today a new addition to their portfolio of proprietary nanocarrier technologies. Amphipathic Peptide Capsules (APC) offer a new way to…

Read Article

March 2023

Phoreus Biotech launches BAPtofect®-25 peptide transfection reagent as a superior alternative to industry-leading, lipid-based reagents

OLATHE, KS, Mar. 1, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, announced today they’ve added a new product to their portfolio of proprietary transfection reagents. The new BAPtofect-25 for general cell…

Read Article

January 2023

Phoreus Biotech Raises $2 Million in Seed Round for Development of New Genetic Vaccines and Therapeutics

OLATHE, KS, Dec. 20, 2022 – Phoreus Biotechnology, a leading provider of next-generation peptide nanocarriers, announced today they have oversubscribed their $2 million dollar seed raise by more than 10 percent. Phoreus Biotech was founded…

Read Article

September 2020

Transfecting Stem Cells Just Got A Lot Easier

All too often, researchers doing cell transfection must conduct a careful balancing act. Achieving a level of transfection that’s high enough to provide reliable results, without killing too many cells in the process, is a…

Read Article

News & Articles The latest in Phoreus & Med Technology

Category: All Posts

How Biopesticides Are Harnessing the Power of Nature

Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers

The Importance of Low-Toxicity Nanoparticles

Phoreus Biotech Releases New Data to Support Elimination of Cold-Chain Storage Requirements for mRNA Vaccines and Therapeutics

New Nanocarrier Technology Promises Breakthrough in Delivery of Therapeutic Drugs Through Mucosal Membranes

Phoreus Biotech launches BAPtofect®-25 peptide transfection reagent as a superior alternative to industry-leading, lipid-based reagents

Phoreus Biotech Raises $2 Million in Seed Round for Development of New Genetic Vaccines and Therapeutics

Transfecting Stem Cells Just Got A Lot Easier

Looking for More?